dimethylphenylpiperazinium iodide has been researched along with Seizures in 2 studies
Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peterson, SL | 1 |
| Armstrong, JJ | 1 |
| Phan, DV | 1 |
| Dóda, M | 1 |
| Bite, A | 1 |
| György, L | 1 |
2 other studies available for dimethylphenylpiperazinium iodide and Seizures
| Article | Year |
|---|---|
Muscarinic receptors mediate carbachol-induced inhibition of maximal electroshock seizures in the nucleus reticularis pontis oralis.
Topics: Animals; Atropine; Carbachol; Cholinergic Agonists; Dimethylphenylpiperazinium Iodide; Electroshock; | 1999 |
Antin ociceptive activity of nicotine.
Topics: Acetates; Analgesia; Animals; Dimethylphenylpiperazinium Iodide; Drug Tolerance; Injections, Intrape | 1973 |